The State of the Psychedelic Industry & Open Questions (Video) Post published:March 3, 2026 Post category:Analysis/News/Pα+
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin Use Post published:February 24, 2026 Post category:Psychedelic Bulletin/Pα+
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data Post published:February 20, 2026 Post category:Analysis/News/Pα+
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast Post published:February 17, 2026 Post category:Analysis/News/Pα+
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions Post published:February 17, 2026 Post category:Analysis/News/Pα+
Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola Post published:February 10, 2026 Post category:Interviews/Pα+
Pα+ Psychedelic Bulletin #219: Trump Admin. Vetoed Compass Priority Voucher; Ibogaine in Focus; Definium Sued by Former Vendor; Psychedelics Feature in Epstein Files Post published:February 6, 2026 Post category:Psychedelic Bulletin/Pα+
Q3 2025: Oregon Psilocybin Services Update Post published:February 2, 2026 Post category:Analysis/News/Pα+